arrow
A

Alexandre Boissonnas

institut mondor de recherche biomedicale
H指数:38
被引数:5,727

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Phase 1, First-in-Human, Randomized, Placebo-Controlled, Dose-Escalating Study to Evaluate OVX033, a Nucleocapsid-Based SARS-CoV-2 Candidate Vaccine

I期,首次人体,随机、安慰剂对照、剂量递增研究,评估OVX033,一种基于核衣壳的SARS-CoV-2候选疫苗

2026-08-120
PRE
Combined pharmacological targeting of CD9+ progenitors alleviates obesity-induced adipose tissue fibrosis and metabolic impairment

联合药理学靶向CD9+祖细胞可缓解肥胖诱导的脂肪组织纤维化和代谢功能障碍

2025-06-180
OAAI
Nuclear envelope disruption triggers hallmarks of aging in lung alveolar macrophages

核膜破坏触发肺泡巨噬细胞衰老的标志

2023-09-186
OA
LOX-1-Expressing Immature Neutrophils Identify Critically-Ill COVID-19 Patients at Risk of Thrombotic Complications

表达LOX-1的未成熟中性粒细胞可识别有血栓并发症风险的重症新型冠状病毒肺炎患者

2021-09-2019
OAAI
TREM-1 orchestrates angiotensin II-induced monocyte trafficking and promotes experimental abdominal aortic aneurysm
2021-01-1950
OA
Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer (July, 10.1038/s41467-020-17644-0, 2020)

激素受体阳性乳腺癌的免疫预防和免疫治疗控制 (7月,10.1038/s41467-020-17644-0,2020)

2020-09-170
OAAI
Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer

激素受体阳性乳腺癌的免疫预防和免疫治疗控制

2020-07-3084
OAAI
Phagocytosis of Wnt inhibitor SFRP4 by late wound macrophages drives chronic Wnt activity for fibrotic skin healing
2020-03-2072
OAAI